Exagen share price today

(XGN)

Exagen share price is $5.15 & ₹437.63 as on 21 Dec 2024, 2.30 'hrs' IST

$5.15

▲

0.44

(9.34%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Exagen share price in Dollar and Rupees. Guide to invest in Exagen from India. Also see the sentimental analysis on Indian investors investing in Exagen. Get details on the Indian mutual funds that are investing in Exagen. Get Analyst recommendations and forecasts along with all the Exagen's financials.

Exagen share price movements

Today's Low: $4.72
Today's High: $5.18
$5.15
8.35%
Downside
Day's Volatility :8.88%
Upside
0.58%
52 Weeks Low: $1.30
52 Weeks High: $6.22
$5.15
74.75%
Downside
52 Weeks Volatility :79.09%
Upside
17.2%

Exagen Returns

Period	Exagen Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	66.13%	-11.1%	0.0%
6 Months	171.05%	-6.0%	0.0%
1 Year	202.94%	2.7%	0.0%
3 Years	-55.49%	0.6%	-19.7%

Exagen Key Statistics

in dollars & INR

Previous Close	$4.71
Open	$4.72
Today's High	$5.18
Today's Low	$4.72
Market Capitalization	$83.1M
Today's Volume	$77.4K
52 Week High	$6.22
52 Week Low	$1.3003
Revenue TTM	$56.7M
EBITDA	$-13.8M
Earnings Per Share (EPS)	$-0.94
Profit Margin	-30.56%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-69.97%

How to invest in Exagen from India?

It is very easy for Indian residents to invest directly in Exagen from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Exagen stock in both Indian Rupees (INR) and US Dollars (USD). Search for Exagen or XGN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Exagen or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Exagen shares which would translate to 0.165 fractional shares of Exagen as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Exagen, in just a few clicks!

Returns in Exagen for Indian investors in Rupees

Investment Value

₹1,00,000

Exagen investment value today

Current value as on today

₹3,05,137

Returns

₹2,05,137

(+205.14%)

Returns from Exagen Stock

₹2,02,941 (+202.94%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Exagen

84%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Exagen on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 84% more investors are searching Exagen in the last 30 days versus the previous period.

Global Institutional Holdings in Exagen

RTW INVESTMENTS, LLC
8.57%
COWEN AND COMPANY, LLC
5.05%
Silvercrest Asset Management Group LLC
3.07%
Stonepine Capital Management Llc
3.03%
Vanguard Group Inc
2.78%
Wasatch Advisors LP
2.78%

Analyst Recommendation on Exagen

Buy

80%Buy

20%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Exagen(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Exagen

What analysts predicted

Upside of 21.36%

Current:

$5.15

Target:

$6.25

Insights on Exagen

Price Movement
In the last 1 month, XGN stock has moved up by 31.4%
Decreasing Revenue
Revenue is down for the last 2 quarters, 15.06M → 12.50M (in $), with an average decrease of 17.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -2.96M → -5.02M (in $), with an average decrease of 69.5% per quarter
XGN vs A (3 yr)
In the last 3 years, Exagen Inc has experienced a drawdown of -55.1%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 36.3%

Exagen Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$32.4M	↑ 21.01%
Net Income	$-8.0M	↓ 68.74%
Net Profit Margin	-24.7%	↑ 70.91%

	FY19	Y/Y Change
Revenue	$40.4M	↑ 24.5%
Net Income	$-12.0M	↑ 50.25%
Net Profit Margin	-29.81%	↓ 5.11%

	FY20	Y/Y Change
Revenue	$42.0M	↑ 3.93%
Net Income	$-16.7M	↑ 38.62%
Net Profit Margin	-39.75%	↓ 9.94%

	FY21	Y/Y Change
Revenue	$48.3M	↑ 15.07%
Net Income	$-26.9M	↑ 60.91%
Net Profit Margin	-55.59%	↓ 15.84%

	FY22	Y/Y Change
Revenue	$45.6M	↓ 5.66%
Net Income	$-47.4M	↑ 76.48%
Net Profit Margin	-104.0%	↓ 48.41%

	FY23	Y/Y Change
Revenue	$52.5M	↑ 15.33%
Net Income	$-23.7M	↓ 50.01%
Net Profit Margin	-45.08%	↑ 58.92%

	Q2 FY23	Q/Q Change
Revenue	$14.1M	↑ 25.89%
Net Income	$-5.0M	↓ 39.66%
Net Profit Margin	-35.46%	↑ 38.52%

	Q3 FY23	Q/Q Change
Revenue	$13.4M	↓ 5.1%
Net Income	$-5.4M	↑ 8.02%
Net Profit Margin	-40.36%	↓ 4.9%

	Q4 FY23	Q/Q Change
Revenue	$13.8M	↑ 2.6%
Net Income	$-5.6M	↑ 2.92%
Net Profit Margin	-40.49%	↓ 0.13%

	Q1 FY24	Q/Q Change
Revenue	$14.4M	↑ 4.72%
Net Income	$-3.4M	↓ 39.71%
Net Profit Margin	-23.31%	↑ 17.18%

	Q2 FY24	Q/Q Change
Revenue	$15.1M	↑ 4.5%
Net Income	$-3.0M	↓ 11.73%
Net Profit Margin	-19.69%	↑ 3.62%

	Q3 FY24	Q/Q Change
Revenue	$12.5M	↓ 16.97%
Net Income	$-5.0M	↑ 69.52%
Net Profit Margin	-40.2%	↓ 20.51%

	FY18	Y/Y Change
Profit	$17.1M	↑ 34.66%

	FY19	Y/Y Change
Profit	$21.6M	↑ 26.48%

	FY20	Y/Y Change
Profit	$25.4M	↑ 17.78%

	FY21	Y/Y Change
Profit	$27.7M	↑ 9.03%

	FY22	Y/Y Change
Profit	$21.3M	↓ 22.96%

	FY23	Y/Y Change
Profit	$29.5M	↑ 37.97%

	Q2 FY23	Q/Q Change
Profit	$8.3M	↑ 56.5%

	Q3 FY23	Q/Q Change
Profit	$7.7M	↓ 7.17%

	Q4 FY23	Q/Q Change
Profit	$8.1M	↑ 5.7%

	Q1 FY24	Q/Q Change
Profit	$8.6M	↑ 5.56%

	Q2 FY24	Q/Q Change
Profit	$9.1M	↑ 5.33%

	Q3 FY24	Q/Q Change
Profit	$7.0M	↓ 22.91%

	FY18	Y/Y Change
Operating Cash Flow	$-9.3M	↓ 15.2%
Investing Cash Flow	$-199.0K	↓ 60.98%
Financing Cash Flow	$11.4M	↓ 40.37%

	FY19	Y/Y Change
Operating Cash Flow	$-9.7M	↑ 4.41%
Investing Cash Flow	$-103.0K	↓ 48.24%
Financing Cash Flow	$68.7M	↑ 501.72%

	FY20	Y/Y Change
Operating Cash Flow	$-14.1M	↑ 45.03%
Investing Cash Flow	$-455.0K	↑ 341.75%
Financing Cash Flow	$-97.0K	↓ 100.14%

	FY21	Y/Y Change
Operating Cash Flow	$-20.3M	↑ 43.92%
Investing Cash Flow	$-2.4M	↑ 431.87%
Financing Cash Flow	$64.7M	↓ 66783.51%

	FY22	Y/Y Change
Operating Cash Flow	$-32.1M	↑ 58.59%
Investing Cash Flow	$-4.3M	↑ 78.43%
Financing Cash Flow	$-489.0K	↓ 100.76%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-10.2M	↑ 4.15%
Investing Cash Flow	$-322.0K	↓ 18.69%
Financing Cash Flow	$-10.2M	↑ 16419.35%

Exagen Technicals Summary

Sell

Neutral

Buy

Exagen is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Exagen Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Exagen Inc	31.38%	171.05%	202.94%	-55.49%	-80.93%
Idexx Laboratories, Inc.	-1.5%	-16.12%	-25.59%	-35.59%	56.17%
Agilent Technologies Inc.	1.86%	-0.42%	-3.63%	-14.2%	57.76%
Thermo Fisher Scientific, Inc.	1.54%	-7.4%	-0.95%	-19.59%	59.75%
Danaher Corp.	-2.77%	-10.99%	-0.79%	-28.51%	49.15%
Iqvia Holdings Inc.	-0.17%	-7.86%	-14.0%	-28.72%	27.38%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Exagen Inc	NA	NA	NA	-0.9	-0.7	-0.17	NA	1.33
Idexx Laboratories, Inc.	39.52	39.52	4.31	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	30.02	30.02	2.26	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	32.35	32.35	1.97	21.7	0.13	0.05	0.0	128.08
Danaher Corp.	42.75	42.75	3.02	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	25.19	25.19	1.01	11.11	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Exagen Inc	Buy	$83.1M	-80.93%	NA	-30.56%
Idexx Laboratories, Inc.	Buy	$33.5B	56.17%	39.52	22.53%
Agilent Technologies Inc.	Buy	$38.4B	57.76%	30.02	21.75%
Thermo Fisher Scientific, Inc.	Buy	$197.6B	59.75%	32.35	14.48%
Danaher Corp.	Buy	$163.3B	49.15%	42.75	16.39%
Iqvia Holdings Inc.	Buy	$35.8B	27.38%	25.19	9.17%

About Exagen

exagen diagnostics, inc. is a patient focused, discovery driven, clia-certified, cap-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of rheumatology and autoimmune diseases. committed to personalized medicine, our avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. for more information on our company, please visit www.exagen.com. for more information on avise testing services, please visit www.avisetest.com.

Organization	Exagen
Employees	174
CEO	Dr. Tina S. Nova Ph.D.
Industry	Health Services

Management People of Exagen

Name	Title
Dr. Tina S. Nova Ph.D.	Executive Chairman of the Board of Directors
Mr. John Aballi	CEO, President & Director
Mr. Kamal Adawi M.S., MBA	Corporate Secretary
Mr. Jeffrey G. Black	Chief Financial Officer
Mr. Ryan Douglas	Investors Relations Officer
Dr. Andrew L. Concoff FACR, M.D.	Chief Innovation Officer & Member of Rheumatoid Arthritis Scientific Advisory Board
Dr. Michael I. Nerenberg M.D.	Chief Medical Officer

Important FAQs about investing in Exagen from India :

What is Exagen share price today?

Exagen share price today stands at $5.15, Open: $4.72 ; Previous Close: $4.71 ; High: $5.18 ; Low: $4.72 ; 52 Week High: $6.22 ; 52 Week Low: $1.30. The stock opens at $4.72, after a previous close of $4.71. The stock reached a daily high of $5.18 and a low of $4.72, with a 52-week high of $6.22 and a 52-week low of $1.30.

Can Indians buy Exagen shares?

Yes, Indians can invest in the Exagen (XGN) from India.

With INDmoney, you can buy Exagen at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Exagen at zero transaction cost.

How can I buy Exagen shares from India?

It is very easy to buy Exagen from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Exagen be purchased?

Yes, you can buy fractional shares of Exagen with INDmoney app.

What are the documents required to start investing in Exagen stocks?

To start investing in Exagen, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.